As
Primary Qualified Person
Astellas Pharma Inc.
Permanent
Ireland, Ireland
Business Operations Specialists
Posted:
March 02, 2026
Location:
Ireland, Ireland, Ireland
Job Description
Description Primary Qualified Person
About AstellasAt Astellas we are making treatments that matter to people. We are tackling the toughest health challenges, placing the patient at the heart of everything we do. Through our global vision for Patient Centricity, we integrate the patient experience into our everyday working practices. We have developed ground breaking medicines in immunology, oncology and urology, improving and saving the lives of patients worldwide.
Are you driven to make a real difference in the lives of patients?
We are seeking individuals who thrive in dynamic environments, embrace new ideas and are committed to making a meaningful impact.
Location and Working Environment
This position is 100% onsite in Tralee, Ireland.Purpose & Scope
The Primary Qualified Person is responsible for the batch release of drug product. Additional responsibilities include the development, implementation, maintenance and con...
About AstellasAt Astellas we are making treatments that matter to people. We are tackling the toughest health challenges, placing the patient at the heart of everything we do. Through our global vision for Patient Centricity, we integrate the patient experience into our everyday working practices. We have developed ground breaking medicines in immunology, oncology and urology, improving and saving the lives of patients worldwide.
Are you driven to make a real difference in the lives of patients?
We are seeking individuals who thrive in dynamic environments, embrace new ideas and are committed to making a meaningful impact.
Location and Working Environment
This position is 100% onsite in Tralee, Ireland.Purpose & Scope
Apply for this Job
Submit your application for the Primary Qualified Person position at Astellas Pharma Inc..
Apply Now Save for LaterJob Overview
Job Type:
Permanent
Location:
Ireland, Ireland
Posted:
March 02, 2026
Deadline:
April 11, 2026